PITTSBURGH, April 25,
2024 /PRNewswire/ -- PANTHERx® Rare,
the leader in rare disease pharmacy, patient access, and
support services in the United
States, is pleased to announce three new expansions that
will facilitate the company's continued growth and enhance its
innovative capabilities to serve more people living with rare and
devastating conditions.
First, the company is expanding geographically beyond its
Pittsburgh-region roots to
Collierville, TN, near
Memphis and FedEx's World
Headquarters. This new facility will become the second
licensed pharmacy and packaging and dispensing
location for PANTHERx Rare®, creating a fully
redundant logistics solution. The Memphis location has over
30,000 sq ft in warehousing and dispensing space, along with an
8,000 sq ft of built-in refrigerator/freezer space to house
temperature-sensitive medications, with a capacity of more than 1.5
million shipments annually. Memphis was selected as the
preferred location for this type of facility as it's known as the
"Supply Chain Capital of the World." The facility will be a
services hub to provide 24/7 support to patients and their
healthcare providers and is expected to be fully operational in
late 2024.
Next, PANTHERx® Rare plans to move its national
headquarters to the Settlers Ridge campus in Pittsburgh, four miles from its current
location, in the fall of 2024. This 65,000 sq ft LEED
Gold-certified HQ creates a responsible, energizing HQ space to
accommodate PANTHERx's future growth and expanding
RxARECARE® programs. The third expansion, also on the
Settlers Ridge campus, will house a world-class dispensing
operation for rare disease, with multiple power sources,
significant generators, and a viewing platform to witness the
operations. The dispensing facility, with over 28,000 sq ft of
warehouse and dispensing space, will significantly increase the
total shipment capacity. It is scheduled for a late 2026
opening.
"As the preeminent rare disease pharmacy, our company continues
to experience tremendous growth in serving an increasing number of
people living with rare conditions who need personalized support,"
said Rob Snyder, CEO of PANTHERx® Rare Pharmacy. "So, to
continue fulfilling our promise to patients and healthcare
professionals, and to our pharmaceutical partners that discover and
develop life-saving treatments, we are investing in these near-term
expansions to dramatically increase our specialty capacity and
capabilities."
About PANTHERx Rare
PANTHERx Rare is a specialty pharmacy purely focused on rare and
orphan diseases, distributing several orphan products and providing
access and support services to those needing them most. Known as
The Rare Disease Pharmacy®, PANTHERx transforms lives by
delivering medicine breakthroughs, clinical excellence, and access
solutions to people living with rare and devastating conditions.
While each rare condition affects few people, together all rare
diseases impact an estimated 25 to 30 million Americans. Currently
over 7,000 rare diseases have been identified and more than 90% of
rare diseases are still without an FDA-approved treatment. Changes
in federal policy and advances in science have led to a surge in
FDA orphan drug approvals, providing tremendous hope to the rare
disease community.
PANTHERx is a dual-accredited specialty pharmacy, holding
distinctions in rare disease including the Accreditation Commission
for Health Care (ACHC) Distinction in Orphan Drugs and Utilization
Review Accreditation Commission (URAC) Rare Disease Center of
Excellence. As a pharmacy focused on patient satisfaction, PANTHERx
is the six-time winner of the prestigious MMIT Patient Choice
Award, including the 2023 honor. PANTHERx is headquartered
in Pittsburgh, Pennsylvania and is licensed in all 50 states and US
territories.
For more information, please
contact marketing@pantherxrare.com
View original
content:https://www.prnewswire.com/news-releases/pantherx-rare-continues-explosive-growth-with-expansions-of-pharmacy-hq-and-distribution-locations-302127767.html
SOURCE PANTHERx Rare Pharmacy